RankingsPricing
  1. US-listed companies
  2. BOSTON SCIENTIFIC CORP
  3. Financials
  4. Free cash flow

BOSTON SCIENTIFIC CORPBSX

Market cap
$145B
P/E ratio
SummaryFinancials
Period EndFree cash flow (Million USD)YoY (%)
Dec 31, 20242,645+47.60%
Dec 31, 20231,792+91.04%
Dec 31, 2022938-28.72%
Dec 31, 20211,316+16.25%
Dec 31, 20201,132-17.67%
Dec 31, 20191,375-23016.67%
Dec 31, 2018-6-100.54%
Dec 31, 20171,107+85.74%
Dec 31, 2016596+68.84%
Dec 31, 2015353-65.05%
Dec 31, 20141,010+20.67%
Dec 31, 2013837-19.05%
Dec 31, 20121,034+46.88%
Dec 31, 2011704+1228.30%
Dec 31, 201053

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)